186 Chapter 8 BMC Cancer 2018; 18(1): 1182. 32. Shi L, Yang X, He L, Zheng C, Ren Z, Warsame JA, et al. Promoter hypermethylation analysis of host genes in cervical intraepithelial neoplasia and cervical cancers on histological cervical specimens. BMC Cancer 2023; 23(1): 168. 33. Xu J, Xu L, Yang B, Wang L, Lin X, Tu H. Assessing methylation status of PAX1 in cervical scrapings, as a novel diagnostic and predictive biomarker, was closely related to screen cervical cancer. Int J Clin Exp Pathol 2015; 8(2): 1674-81. 34. Liou YL, Zhang TL, Yan T, Yeh CT, Kang YN, Cao L, et al. Combined clinical and genetic testing algorithm for cervical cancer diagnosis. Clin Epigenetics 2016; 8: 66. 35. Huang TH, Lai HC, Liu HW, Lin CJ, Wang KH, Ding DC, et al. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer. Int J Gynecol Cancer 2010; 20(4): 513-9. 36. Schmitz M, Eichelkraut K, Schmidt D, Zeiser I, Hilal Z, Tettenborn Z, et al. Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages. BMC Cancer 2018; 18(1): 1197. 37. Liang H, Li GL, Liu J, Fu M, Huang H, Zhao K, et al. The application value of PAX1 and ZNF582 gene methylation in high grade intraepithelial lesion and cervical cancer. Clin Transl Oncol 2021; 23(2): 283-8. 38. Lehtinen M, Pimenoff VN, Nedjai B, Louvanto K, Verhoef L, Heideman DAM, et al. Assessing the risk of cervical neoplasia in the post-HPV vaccination era. Int J Cancer 2023; 152(6): 1060-8. 39. Eijsink JJ, Yang N, Lendvai A, Klip HG, Volders HH, Buikema HJ, et al. Detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages, a feasibility study. Gynecol Oncol 2011; 120(2): 280-3. 40. Hesselink AT, Heideman DA, Steenbergen RD, Gök M, van Kemenade FJ, Wilting SM, et al. Methylation marker analysis of selfsampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy. Int J Cancer 2014; 135(4): 880-6. 41. Verhoef VM, Bosgraaf RP, van Kemenade FJ, Rozendaal L, Heideman DA, Hesselink AT, et al. Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial. Lancet Oncol 2014; 15(3): 315-22. 42. Floore A, Hesselink A, Oštrbenk A, Alcaniz E, Rothe B, Pedersen H, et al. Intra- and inter-laboratory agreement of the FAM19A4/miR124-2 methylation test: Results from an international study. J Clin Lab Anal 2019; 33(4): e22854. 43. Verlaat W, Van Leeuwen RW, Novianti PW, Schuuring E, Meijer C, Van Der Zee AGJ, et al. Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer. Epigenetics 2018; 13(7): 769-78. 44. Vink FJ, Meijer C, Hesselink AT, Floore AN, Lissenberg-Witte BI, Bonde JH, et al. FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years. Clin Infect Dis 2023; 76(3): e827-e34. 45. Louvanto K, Aro K, Nedjai B, Bützow R, Jakobsson M, Kalliala I, et al. Methylation in Predicting Progression of Untreated Highgrade Cervical Intraepithelial Neoplasia. Clin Infect Dis 2020; 70(12): 2582-90. 46. Kremer WW, Dick S, Heideman DAM, Steenbergen RDM, Bleeker MCG, Verhoeve HR, et al. Clinical Regression of HighGrade Cervical Intraepithelial Neoplasia Is Associated With Absence of FAM19A4/ miR124-2 DNA Methylation (CONCERVE Study). J Clin Oncol 2022; 40(26): 3037-46. 47. Rijkaart DC, Berkhof J, van Kemenade FJ, Coupe VM, Hesselink AT, Rozendaal L, et al. Evaluation of 14 triage strategies for
RkJQdWJsaXNoZXIy MjY0ODMw